Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up

Acta Myol. 2022 Jun 30;41(2):101. eCollection 2022 Jun.

Authors

Amir Dori, Michela Guglieri, Marianna Scutifero, Luigia Passamano, Antonio Trabacca, Luisa Politano

PMID: 35919205
PMCID: PMC9299955

Abstract

[This retracts the article DOI: 10.36185/2532-1900-058.].

©2022 Gaetano Conte Academy - Mediterranean Society of Myology.

Publication types

Retraction of Publication